MCI guidelines on generic drugs being flouted in J&K, alleges DAK

Srinagar, Sep 8: Alleging that Medical Council of India (MCI) guidelines on generic drugs are being flouted in the state, Doctors Association Kashmir (DAK) today said that doctors are prescribing expensive branded drugs thus preventing access to economical medicines for the poor.

    “Doctors in Jammu and Kashmir are prescribing brand-name drugs in violation to the recommendations of the MCI, which mandates prescribing of generic drugs. MCI, the statutory body that registers doctors to ensure proper standards of medical practice, on September 2016 amended Clause 1.5 of the Indian Medical Council (Professional conduct, etiquette and ethics), Regulations 2002 mandating doctors to prescribe generic medicines,” DAK president Dr Nisar ul Hassan said.     Earlier this year, the MCI reiterated its directive asking doctors to prescribe generic drugs failing which strict disciplinary action will be taken against those violating the code.       He said the move was taken with a view to make medicines accessible to the poor as they are not able to buy the branded medicines. “Clinician are fed and bred by Pharma companies for pushing patients to purchase branded medicines. From luxury cars, family trips to household items, Pharma companies provide doctors everything to prescribe these costly drugs,” the DAK president alleged.    This unholy nexus, he said, is misleading public and has generated a false perception regarding generics that prevents these drugs from getting popular.     “Even the chemists get huge margins for selling branded drugs. Generic drugs are copycat versions of branded drugs and cost 80 to 90 per cent less than branded medicines as manufacturers do not have to spend on development and promotion of the drug,’ he said.    He said Lyrica, the drug used for nerve problems, costs Rs 842 a strip (14 tablets) whereas its generic version costs a meager Rs 70.     Similarly, he said Glivec, the branded drug, used for treating blood cancer is sold at a monthly cost of Rs 1.2 lakh while its generic version is sold at Rs 8000 only.    “Unless a legal framework is put in place, the push for generic medicines will remain only an idea without implementation,” Dr Hassan said. UNI